Digital PET/CT Using [Ga-68]PSMA for Characterization of Prostate Lesions
Status:
Recruiting
Trial end date:
2023-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate a radioactive diagnostic study drug, which is called
Gallium-68 Prostate Specific Membrane Antigen ([Ga-68]PSMA) for characterization of prostate
abnormalities.